SCHEMBL181001

SCHEMBL181001

C1#CCCCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14362121 1.00
SCHEMBL16534583 1.00
SCHEMBL10527801 1.00
SCHEMBL563490 1.00
SCHEMBL3756290 1.00
SCHEMBL180919 1.00
SCHEMBL1139908 1.00
SCHEMBL3198984 1.00
SCHEMBL585520 1.00
SCHEMBL1140387 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 12346 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746918-A1 METHODS OF PREPARING SURFACE MODIFIED VIRAL CAPSIDS Borea Therapeutics S.r.l. (IT) 2026-05-27 EP claimed
EP-4747371-A1 CHEMOGENETIC SURFACE MODIFIED VIRAL PARTICLES Borea Therapeutics S.r.l. (IT) 2026-05-27 EP claimed
CN-122075727-A Subcellular targeting drug delivery conjugate, preparation method, composition and application thereof 2026-05-26 CN claimed
CN-122075733-A Preparation method and application of linker medicine and antibody-medicine conjugate thereof 2026-05-26 CN claimed
CN-122084358-A Multiple histochemical staining method based on controllable staining-decoloring circulation 2026-05-26 CN claimed
EP-3946460-B1 IMPROVED CONJUGATION LINKERS PROLYNX LLC (US) 2026-05-20 EP claimed
WO-2026102134-A1 ANALYTE BINDING COMPOSITIONS, METHODS, AND SYSTEMS FREENOME HOLDINGS, INC. (US) 2026-05-15 WO claimed
CN-122031713-A Preparation method and application of linker medicine and antibody-medicine conjugate thereof 乐普生物科技股份有限公司 2026-05-15 CN claimed
EP-4308715-B1 HYBRID MOLECULE COMPRISING AN ANTIBODY FC FRAGMENT AND AT LEAST ONE FIBRIN-DERIVED CITRULLINATED PEPTIDE, AND USES THEREOF UNIV TOULOUSE 3 PAUL SABATIER (FR) 2026-05-13 EP claimed
EP-4308716-B1 HYBRID MOLECULE COMPRISING A FIBRIN-DERIVED CITRULLINATED PEPTIDE AND AN ANTIBODY OR ANTIBODY FRAGMENT WHICH BINDS TO CD38 AND/OR CD138, AND USES THEREOF UNIV TOULOUSE 3 PAUL SABATIER (FR) 2026-05-13 EP claimed
EP-0194525-B1 N-CARBAMOYL-AZOLES AND FUNGICIDES CONTAINING THEM BASF Aktiengesellschaft (DE) 1988-08-10 EP claimed
EP-0168415-B1 UTILIZATION OF SALICYLIC ACID ESTERS AS PERFUMING SUBSTANCES, PERFUMING COMPOSITIONS CONTAINING THEM AND NEW SALICYLIC ACID ESTERS Henkel Kommanditgesellschaft auf Aktien (DE) 1987-08-12 EP claimed
EP-0100898-B1 CYCLOALKYL DERIVATIVES OF BENZISOSELENAZOLONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM A. Nattermann & Cie. GmbH (DE) 1987-05-13 EP claimed
EP-0085811-B1 2-(PHENYLMETHYLENE)CYCLOALKYLAMINES THE UPJOHN COMPANY (US) 1986-05-07 EP claimed
EP-0069070-B1 COLOUR PHOTOGRAPHIC MATERIALS CONTAINING STABILIZERS CIBA-GEIGY AG (CH) 1986-02-05 EP claimed
EP-0098241-B1 HYDROQUINONE ETHERS AND A PROCESS FOR PREPARING THEM CIBA-GEIGY AG (CH) 1985-10-02 EP claimed
EP-0056787-B1 PHOTOGRAPHIC RECORDING MATERIAL AND PROCESS FOR ITS PREPARATION CIBA-GEIGY AG (CH) 1985-06-19 EP claimed
EP-0046572-B1 6-QUINAZOLINESULFONYL DERIVATIVES AND PROCESS FOR PREPARATION THEREOF Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1984-10-31 EP claimed
EP-0062887-B1 INDOLINONE-2 DERIVATIVES, PROCESS FOR THEIR PREPARATION AND NEURO-ANABOLIC MEDIUMS CONTAINING THEM HOECHST AKTIENGESELLSCHAFT (DE) 1984-07-11 EP claimed
EP-0000950-B1 IMIDAZOLE DERIVATIVES AND SALTS THEREOF AND THEIR SYNTHESIS THE WELLCOME FOUNDATION LIMITED (GB) 1984-02-01 EP claimed